DHR vs MAR: Which Is the Better Buy?
Side-by-side comparison of Danaher Corporation and Marriott International, Inc. — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-05-04.
Danaher Corporation · Healthcare
$174.04
+13.2% upside to fair value
Grade B
VS
Marriott International, Inc. · Consumer Cyclical
$377.93
-13.8% upside to fair value
Grade D
QuantHub Verdict
DHR has more upside to fair value
(+13.2%).
DHR trades at a lower forward P/E
(33.4x).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
DHR |
MAR |
| Current Price |
$174.04 |
$377.93 |
| Fair Value Estimate |
$197.01 |
$325.87 |
| Upside to Fair Value |
+13.2%
|
-13.8%
|
| Market Cap |
$123.2B |
$100.2B |
| Forward P/E |
33.4x
|
39.0x
|
| EV / EBITDA |
20.3x
|
25.3x
|
| Price / Sales |
5.0x
|
3.8x
|
| Price / FCF |
23.3x
|
34.6x
|
| Revenue Growth YoY |
+3.7%
|
+4.1%
|
| Gross Margin |
60.7%
|
21.3%
|
| Operating Margin |
21.0%
|
15.8%
|
| Return on Equity |
7.1%
|
-79.9%
|
| Dividend Yield |
0% |
0% |
| FCF Yield |
4.3%
|
2.89%
|
| Analyst Consensus |
Strong Buy
|
Hold
|
Investment Thesis
Danaher Corporation is a diversified healthcare company focused on medical diagnostics, life sciences, and biotechnology, generating approximately $24 billion in revenue with a strong recurring revenue base of over 81%. The company benefits from a high gross margin of 60.7% and solid operating margin of 21%, supported by a seasoned management team with a proven capital allocation track record inc…
Marriott International, Inc. operates as the world's largest hospitality company with approximately 9,000 to 9,700 properties across 141 to 143 countries and territories, managing over 30 brands and the largest loyalty program with 203 to 248 million members. The company benefits from a durable competitive moat driven by scale, brand strength, and a growing asset-light credit card royalty busines…
Accumulation Zones
| Metric |
DHR |
MAR |
| Zone Low |
$147.76 |
$244.40 |
| Zone High |
$167.46 |
$276.99 |
| In Buy Zone? |
No
|
No
|